Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda
about
Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-AnalysisMultidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in ChinaRates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infectionEffectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort studyHigh prevalence of primary multidrug resistant tuberculosis in persons with no known risk factorsRifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysisAetiology of pulmonary symptoms in HIV-infected smear negative recurrent PTB suspects in Kampala, Uganda: a cross-sectional studyElucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencingAssociation between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistanceAssociation between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysisThe Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative BacilliThe Role of Adherence and Retreatment in De Novo Emergence of MDR-TBComparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda.Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study.Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technologyUse of the GenoType(R) MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural UgandaRisk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in MoroccoTuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs.Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South AfricaHigh Frequency of First-Line Anti-Tuberculosis Drug Resistance among Persons with Chronic Pulmonary Tuberculosis at a Teaching Hospital Chest Clinic.Characteristics of multidrug-resistant tuberculosis in Namibia.Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis."Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study.Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia.Tuberculosis retreatment 'others' in comparison with classical retreatment cases; a retrospective cohort review.First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis.Prevalence of positive tuberculin skin test and associated factors among Makerere medical students, Kampala, Uganda.Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.Genotypic Detection of rpoB and katG Gene Mutations Associated with Rifampicin and Isoniazid Resistance in Mycobacterium Tuberculosis Isolates: A Local Scenario (Kelantan).Epidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa.The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: part I: the origins and nature of the problem.Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia.The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: Part II: scientific advances that may provide solutionsTuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.
P2860
Q26781111-73520EB4-DD39-4137-9FFA-1B1129E0D4EBQ28386082-3CFAF092-F216-4F6E-A407-E6A05F5BB3DDQ28476713-16422B18-D11A-4F32-AE16-BB93C37799B1Q28477435-4801ED4E-53B3-4996-968B-BD32F9DFF54DQ28477658-38D2AD93-506E-49D3-9C56-5913A8945E8FQ28480467-B133AD30-C063-427F-BD9A-98175C75C205Q28535816-5423FC54-CB13-411B-A997-A7F9C52F75C4Q28536869-92FA266E-33EC-4489-8DAB-2B0108EF6558Q28537951-D5002BE8-3529-4164-AC38-7E20CCFD2928Q28538427-4B46C8BF-4595-4FC6-877B-DCB08D974285Q28546927-9AA86AED-66E0-4B66-9437-2D0D2AE617BAQ28550707-717A03D0-BB6A-466F-B190-3F1AAC161FD4Q33497027-6CF15A7C-F5AA-4114-A754-A9DF455181FEQ33586629-6E197B96-6EE4-4254-A838-C9B67B21EC20Q33614228-3FEA7CDA-1FAC-48E8-AB19-CD9641A1B248Q33651616-ABA404A5-DE7E-493F-839F-D84732E74D3CQ33830959-8F2C1575-1409-4D70-A1C6-2A7953219150Q33994134-ACD07556-B848-4848-92EA-DDB39B95458DQ34216252-1DA20A76-084E-45FC-B387-359095376BC0Q34363124-253565F3-9F81-448D-A747-AD380E43188EQ34526722-DE3641E8-0342-4911-A5E7-FBF6FA01E3D0Q35017694-A45CA46D-FCA6-4BAE-92CB-F91A9DF8A1ABQ35100096-64A4B5FE-2EC2-4D6E-99B4-745E560B2DBBQ35621974-1B018C99-1337-46D9-A3BF-1B5964700AE4Q35673445-03290F57-B8CC-4E44-9E10-E7DD8294BFCAQ35681236-226E0A5C-EBF3-43BF-B19C-3E65221673F9Q35761800-60911A99-A0B6-4FA5-8FD0-9A7AF62E4530Q35990621-CD7994F7-0DB5-4754-B32F-38CBA7B80D2BQ36612565-4A1AF667-3E91-4F26-99BF-546D55DF7827Q36822433-3C5DE52D-4A04-4045-AFFF-D9909FD80667Q37155860-8040D180-057D-4DD1-92F7-29F500FE2F57Q37423406-DF54F6A5-F1E7-441B-934C-7EDA6ADC614EQ37700331-44464E4E-B53D-4712-86F5-AB03F2BAFEB1Q37702443-7882C323-E25E-48CE-92C5-DFB55ED8BE2EQ37742687-5CE12E7E-E070-4891-B00E-A4BF70E30E41Q38002002-47C00790-8EA5-422F-9FF6-EE24AC1BECD4
P2860
Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Rate and amplification of drug ...... uberculosis in Kampala, Uganda
@ast
Rate and amplification of drug ...... uberculosis in Kampala, Uganda
@en
type
label
Rate and amplification of drug ...... uberculosis in Kampala, Uganda
@ast
Rate and amplification of drug ...... uberculosis in Kampala, Uganda
@en
prefLabel
Rate and amplification of drug ...... uberculosis in Kampala, Uganda
@ast
Rate and amplification of drug ...... uberculosis in Kampala, Uganda
@en
P2093
P2860
P50
P356
P1476
Rate and amplification of drug ...... uberculosis in Kampala, Uganda
@en
P2093
Alphonse Okwera
Beth Temple
Helen Nabanjja
Irene Ayakaka
Jonathan Levin
Kathleen D Eisenach
Roy D Mugerwa
Sam Ogwang
Susan Kayes
Susan Nakubulwa
P2860
P304
P356
10.1086/592252
P407
P577
2008-11-01T00:00:00Z